Skip to main content
. 2020 Sep 17;11:1036. doi: 10.3389/fneur.2020.01036

Figure 3.

Figure 3

Hazard ratios and 95% confidence intervals of the association between carmustine implantation and overall survival in patients with different pathological grades of glioma (A), in newly diagnosed and recurrent GBM (B), and in patients with TMZ chemotherapy and TMZ plus carmustine chemotherapy (C). CI, confidence interval; df, degrees of freedom; SE, standard error.